Immunization schedule of the Spanish Association of Pediatrics: Recommendations 2008;Calendario vacunal de la Asociación Española de Pediatría: Recomendaciones 2008

Anales de Pediatria

Volumn 68, Issue 1, 2008, Pages 63-69

  Bernaola Iturbe, E ^a,b   Gimenez Sanchez F ^a   Baca Cots, M ^a   De Juan Martin F ^a   Diez Domingo J ^a   Garces Sanchez M ^a   Gomez Campdera A ^a   Martinon Torres F ^a   Picazo, J J ^a   Pineda Solas V ^a  

^a Hospital Clínico   (Spain)

^b NONE   (Spain)

Author keywords

Combined vaccines; Immunization schedule; Immunizations; Vaccination strategies; Vaccine preventable diseases; Vaccines

Indexed keywords

ALUMINUM; ATROPINE; CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ADJUVANT THERAPY; CONDYLOMA ACUMINATUM; COUGHING; DIPHTHERIA; HEPATITIS A; HEPATITIS A VIRUS; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFLUENZA; REVIEW; RUBELLA; SOCIAL WELFARE; TETANUS; UTERINE CERVIX CANCER; VACCINATION; VACCINE FAILURE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WART VIRUS;

EID: 38349011083     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13114474     Document Type: Article

References (50)

1. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la AEP. An Esp Pediatr. 1999;51:120-6.
2. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría 2001-2002. An Esp Pediatr. 2001;55:30-8.
3. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría 2003. An Pediatr (Barc). 2003;58:257-62.
4. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2004. An Pediatr (Barc). 2004;60:468-72.
5. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2005. An Pediatr (Barc). 2005;62:158-60.
6. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2006. An Pediatr (Barc). 2006;64:74-7.
7. Comité Asesor de Vacunas de la AEP. Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2007. An Pediatr (Barc). 2007;66:62-6.
8. Campins-Martí M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescents and adults pertussis immunization rationale and consideration. Vaccine. 2002;20:641-6.
9. Larrauri A, Cano R, García M, Mateo S. Impact and effectiveness of meninigococcal C conjugate vaccine following its introduction in Spain. Vaccine. 2005;23:4097-100.
10. Vu DM, Kelly D, Heath PT, McCarthy MD, Pollard AJ, Granoff DM. Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization. J Infect Dis. 2006; 194:31-7.
11. Measles, mumps and rubella, Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of Advisory Committee on Immunization Practices (ACIP). MMWR. 1998; 47(RR-8):1-57.
12. Consejería de Sanidad y Consumo Comunidad de Madrid. Disponible en: http://www.vacunasaep.org/noticias/calendario_madrid_2006.htm
13. Consejería de Salud Comunidad Foral de Navarra Calendario Vacunal 2007. Disponible en: http://www.navarra.es/home_es/Actualidad/Noticias/Salud/
14. Public Health Response to varicella outbreaks United States 2003-2004. MMWR. 2006;55:993-5.
15. Prevention of Varicella Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;56(RR04):1-40.
16. Committee Infectious Disease. American Academy of Pediatrics. Prevention of varicella: Recommendations for use of varicella vaccines in children, including recommendation for a routine 2-dose varicella immunization schedule. Pedatrics. 2007;120:221-31.
17. Casado-Flores J, Aristegui J, Rodrigo C, Martinón JM, García-Rey C, García-Escribano N. Decrease in pneumococcal meningitis incidence in Spain after heptavalent pneumococcal conjugate vaccine licensure. 25th ESPID, 2007. Porto. Portugal. Book Abstracts no. 557. WHO.
18. Pneumococcal conjugate vaccine for childhood immunization. WHO position paper. Weekly Epidemiol Record. 2007;82:93-104.
19. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: A matched case-control study. Lancet. 2006;368(9546):1495-502.
20. Bosch FX, Bernaola Iturbe E. La vacuna frente al virus del papiloma humano y la incorporación de la pediatría a la prevención del cáncer de cuello uterino. An Pediatr (Barc). 2006;65:411-3.
21. Martinón-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martín F, Díez Domingo J, et al. Vacuna frente al virus del papiloma humano: un nuevo reto para el pediatra. An Pediatr (Barc). 2006;65:461-9.
22. Ficha técnica e informes de la Agencia Europea del Medicamento (EMEA) sobre Gardasil. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/ EPAR/gardasil/H-703-PI-es.pdf.
23. Ficha técnica e informes de la Agencia Europea del Medicamento (EMEA) sobre Cervarix. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/ EPAR/cervarix/H-721-PI-e.pdf
24. Ficha técnica e informes de la Agencia Europea del Medicamento (EMEA) sobre Rotarix. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/ EPAR/rotarix/H-639-PI-es.pdf
25. Ficha técnica e informes de la Agencia Europea del Medicamento (EMEA) sobre Rotateq. Disponible en: http://www.emea.europa.eu/humandocs/Humans/ EPAR/rotateq/rotateq.htm
26. Giménez Sánchez F, Martinón Torres F, Bernaola Iturbe E, Baca Cots M, De Juan Martín F, et al. El papel de la vacuna frente a rotavirus en los calendarios de vacunación infantil. An Pediatr (Barc). 2006;64:573-7.
27. Recomendaciones Europeas para la Vacunación Antirrotavirus ESPID/ESPGHAN. Pendientes de publicación (Presentadas en el ESPID 2007, 1-4 de Mayo, Oporto, Portugal).
28. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention of rotavirus gastroenteritis among infants and children. MMWR. 2006;55:1-13.
29. Rotavirus vaccine (WER 2007;32:285-96). Disponible en: http://www.who.int/wer/2007/wer8232.pdf
30. Martinón-Torres F, Bouzón-Alejandro M, López Sousa M, Redondo Collazo L, Almeida Agudín S, Astrogano Fernández C, et al. An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain. Eur J Pediatr. 2007 [Epub ahead of print] (DOI 10.1007/s00431-007-0466-3).
31. Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M; REVEAL Study Group. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: The REVEAL Study. J Infect Dis. 2007 May 1;195 Suppl 1:36-44.
32. Calvo C, García ML, Casas I, Martín del Valle F, Centeno M, Pérez-Breña P, et al. Infecciones por virus de la gripe en menores de 2 años. An Pediatr (Barc). 2005;63:22-8.
33. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342:225-31.
34. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-9.
35. Neuzil KM, Zhu Y, Griffen MR, Edwards KM, Thompson JM, Tollefson SJ, et al. Burden of interpandemic influenza in children younger than 5 years: A 25-year prospective study. J Infect Dis. 2002;185:147-52.
36. Kuehn BM. CDC: Immunize more children for influenza. JAMA. 2006;295:2709.
37. Montes M, Vicente D, Pérez-Yarza EG, Cilla G, Pérez- Trallero E. Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: A 3-year study (july 2001-june 2004). Vaccine. 2005;23:4302-6.
38. Aróstegui N, Montes M, Pérez Yarza EG, Sardon O, Cilla G. Características clínicas de los niños hospitalizados por infección por virus influenza. An Pediatr (Barc). 2005;62:5-12.
39. Rojo JC, Ruiz-Contreras J, Fernández MB, Marín MA, Folgueira L. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J. 2006;25:596-601.
40. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med. 1996;150:733-9.
41. Bialek SR, Thoroughman DA, Hu D, Simard EP, Chattin J, Cheek J, et al. Hepatitis A incidence and hepatitis A vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health. 2004;94:996-1001.
42. Amon JJ, Darling N, Fiore AE, Bell BP, Barker LE. Factors associated with hepatitis A vaccination among children 24 to 35 months of age: United States, 2003. Pediatrics. 2006;117:30-3.
43. Dagan R, Levhental A, Aris E, Slater P, Shouval D. Incidence of hepatitis A in Israel following universal immunization in toddlers. JAMA. 2005;294:194-201.
44. Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics. 2007;119:e12-e21.
45. Armstrong GL, Billah K, Rein DB, Hicks K, Wirth KE, Bell BP. The economics of routine childhood hepatitis a immunization in the United States: The impact of herd immunity. Pediatrics. 2007;119:22-9.
46. Vigilancia hepatitis A en España años 1997-2000. Bol Epidemiol Semanal. 2001;9:139.
47. Junqueras S, Mateos M, Lasa E, Chacón J, Baquero F. Seroepidemiologic study of Madrid during the year 2002. Enfer Infecc Microbiol Clin. 2004;22:448.
48. Servicio de Epidemiología y Salud Laboral. Consejería de Salud Junta de Andalucía. Monografías. Informe sobre la hepatitis A. Julio 2006.
49. Oviedo M, Muñoz MP, Domínguez A, Carmona G. Estimated incidence of hepatitis A virus infection in Cataluña. Ann Epidemiol. 2006;16:812-9.
50. Navas E, Salleras L, Gisbert R, Domínguez A, Bruguera M, Rodríguez G, et al. Efficiency of the incorporation of the hepatitis A vaccine as a combined A + B vaccine to the hepatitis B vaccination programme of preadolescents in schools. Vaccine. 2005;23:2185-9.